Complimentary Lecture Series 

We are pleased to announce the launch of a new webinar series through the ASPC called CardioCore: Foundational Lectures in Cardiovascular Disease Prevention. This series is aimed primarily at trainees (though anyone is free to attend) who may not have access to dedicated preventive cardiology programs at their home institutions.  We are planning to present one lecture each month.

Join us each month for complimentary CardioCore Lecture series hosted and moderated by leading clinicians in the field of Preventive Cardiology! 

Missed a CardioCore Lecture? Click below to view. Check back each month for a new CardioCore Lecture!

The Role of CAC Testing in Preventive Cardiology
Dr. Khurram Nasir
June 18, 2025

Updated Management of Hypertension in Prevention of CVD
Dr. Keith Ferdinand

July 8, 2025

 

Cardiovascular Risk Prediction: From Framingham to Prevent
Dr. Sadiya Khan 
August 19, 2025

 

Residual Risk of Cardiovascular Disease
Dr. Vijay Nambi 
September 22, 2025

Role of Inflammation in Cardiovascular Disease
Dr. Brittany Weber
October 22, 2025



Role of Physical Activity in Cardiovascular Health and Prevention of CVD
Dr. Charles German
November 19, 2025 

Diabetes and Cardiometabolic Risk Management
Dr. Neha Pagidipati
January 19, 2026



Dietary Approaches to Reduce CVD Risk
Dr. Robert Ostfeld
February 26, 2026

Beyond Traditional Risk Scores: Imaging in CVD Prevention
Dr. Dharmesh Patel
March 24, 2026
5:00 - 6:00 PM EDT

Register Today!

Upcoming CardioCore Lectures-

  • Aspirin in Primary Prevention: Current Evidence and Controversies
  • ApoB: The Gold Standard for Lipoprotein-Driven Cardiovascular Risk
  • Obesity and Weight Management in CVD Prevention
  • Current and Emerging Therapies for LDL-C Lowering
  • Triglycerides, Remnant Cholesterol, and Cardiovascular Risk
  • Lp(a): Screening, Management, and Cardiovascular Outcomes
  • Familial Hypercholesterolemia and Early CVD Prevention
  • Genetic Risk Scores and Personalized Medicine in CVD Prevention
  • Sex Differences in Cardiovascular Disease Prevention
  • Hormone (estrogen and testosterone) Replacement Therapy and CVD Risk in Women